Listeria Epitopes TCR Transgenics Antigen Sensitivity and Early Signaling
李斯特菌表位 TCR 转基因抗原敏感性和早期信号传导
基本信息
- 批准号:7467909
- 负责人:
- 金额:$ 36.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AgonistAntigensArtsAvidityBiochemistryBiological AssayBiological ModelsBlast CellCD4 Positive T LymphocytesCalciumCellsCellular ImmunityCellular ImmunologyCellular biologyClassCompatibleDataDevelopmentDimerizationEpitopesEventGoalsHistocompatibility Antigens Class IIImageImmune responseImmunityImmunocompromised HostIn VitroInfectionInterferonsInterleukin-2LaboratoriesLigandsListeriaListeria monocytogenesListeriosisMHC Class I GenesMHC Class II GenesMacrophage ActivationMature T-LymphocyteMemoryModelingMolecularMusNatural Killer CellsNumbersOvalbuminOvumPeptide/MHC ComplexPeptidesProductionProliferatingPropertyReagentResearch PersonnelRoleRole playing therapySensitivity and SpecificitySeriesSignal TransductionStagingT memory cellT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTestingTimeTransgenic MiceTransgenic OrganismsVirulenceWeekWorkcomputer studiesdayexperienceinsightinterestkillingsmembrane modelpathogenprogramsresearch studyresponsesingle moleculesynaptogenesis
项目摘要
In the past 30 years or so, intensive work on T cell responses to 'model' antigens has resulted in a great deal
of insight into T cell biology and function, particularly as it relates to the recognition of specific peptide-MHC
complexes through the T cell receptor for antigen.
Of particular relevance to this project, there is now good evidence that mature T cell blasts are sensitive to
even a single molecule of an agonist (peptide-MHC) ligand and that this extraordinary sensitivity is at least in
Dart achieved by the engagement of particular endogenous peptide-MHC complexes together with the
agonist in triggering TCR dimerization. We now wish to extend these studies to the analysis of CD4 and CDS
T cell responsiveness as different times and with different developmental stages of T cells during Listeria
monocytogenes infection in mice.
We particularly wish to test the hypothesis that T cells which emerge as dominant during Listeria infection do
so because they have superior signaling properties.
These studies will involve making a series of CD4transgenics specific for a Listeria LLO epitope and
assaying these transgenic cells for sensitivity and ability to be protective throughout. This project will involve
the close interfacing between highly quantitative experimental data and state of the art modeling techniques.
在过去的30年左右,T细胞对“模型”抗原的反应的深入研究已经产生了大量的结果。
深入了解T细胞生物学和功能,特别是当它涉及到特定的肽-MHC的识别
复合物通过T细胞受体抗原。
与该项目特别相关的是,现在有充分的证据表明成熟T细胞母细胞对
即使是单个分子的激动剂(肽-MHC)配体,这种非凡的敏感性至少在
通过特定的内源性肽-MHC复合物与免疫球蛋白的结合而实现的飞镖。
激动剂触发TCR二聚化。我们现在希望将这些研究扩展到CD 4和CDS的分析。
李斯特菌感染过程中不同时间和不同发育阶段的T细胞反应性
单核细胞增多症感染小鼠。
我们特别希望检验这样一个假设,即在李斯特菌感染过程中占优势的T细胞,
这是因为它们具有优良的上级信号特性。
这些研究将涉及制备一系列对李斯特菌LLO表位具有特异性的CD 4转基因物,
检测这些转基因细胞的敏感性和保护能力。该项目将涉及
高度定量的实验数据和最先进的建模技术之间的密切联系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Morris Davis其他文献
Mark Morris Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Morris Davis', 18)}}的其他基金
Systems biological assessment of T cell responses to vaccination
T 细胞对疫苗接种反应的系统生物学评估
- 批准号:
10584571 - 财政年份:2022
- 资助金额:
$ 36.76万 - 项目类别:
Systems biological assessment of T cell responses to vaccination
T 细胞对疫苗接种反应的系统生物学评估
- 批准号:
10419280 - 财政年份:2022
- 资助金额:
$ 36.76万 - 项目类别:
Molecular interception and immunological characterization of age-associated disease
年龄相关疾病的分子拦截和免疫学表征
- 批准号:
10190562 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
高分辨率纵向免疫监测阐明免疫衰老动态
- 批准号:
10190557 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
高分辨率纵向免疫监测阐明免疫衰老动态
- 批准号:
10491673 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
高分辨率纵向免疫监测阐明免疫衰老动态
- 批准号:
10687219 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
Molecular interception and immunological characterization of age-associated disease
年龄相关疾病的分子拦截和免疫学表征
- 批准号:
10687228 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别: